Netpharm Consulting ApS — Credit Rating and Financial Key Figures
CVR number: 41104554
Granstuevej 7, Øverød 2840 Holte
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 152.56 | ||||
| External services | -12.34 | - 152.36 | |||
| Gross profit | -12.34 | 0.20 | -19.81 | -14.29 | |
| EBIT | -12.34 | 0.20 | -10.06 | -19.81 | -14.29 |
| Pre-tax profit | -12.34 | 0.20 | -10.06 | -19.81 | -14.29 |
| Net earnings | -12.34 | 0.20 | -10.06 | -19.81 | -14.29 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Short term receivables total | |||||
| Cash and bank deposits | 27.66 | 77.86 | 67.80 | 47.99 | 33.71 |
| Cash and cash equivalents | 27.66 | 77.86 | 67.80 | 47.99 | 33.71 |
| Balance sheet total (assets) | 27.66 | 77.86 | 67.80 | 47.99 | 33.71 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 77.86 | 67.80 | 47.99 | 33.71 |
| Retained earnings | -0.20 | 10.06 | 19.81 | 14.29 | |
| Profit of the financial year | -12.34 | 0.20 | -10.06 | -19.81 | -14.29 |
| Shareholders equity total | 27.66 | 77.86 | 67.80 | 47.99 | 33.71 |
| Non-current liabilities total | |||||
| Current liabilities total | |||||
| Balance sheet total (liabilities) | 27.66 | 77.86 | 67.80 | 47.99 | 33.71 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.